KannaLife Sciences, Inc.
Pharmaceutical company · West Hills, New York, United States
KannaLife Sciences, Inc. is a pharmaceutical company headquartered in West Hills, New York, United States. Its earliest recorded incorporation is in 2010. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $3.3 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2013.
KannaLife Sciences at a glance
What does KannaLife Sciences do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $3.3 million in total (2018 to 2021). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Institute on Drug Abuse.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $1.5 million sold (2013).
Frequently asked questions about KannaLife Sciences
Where is KannaLife Sciences headquartered?
KannaLife Sciences, Inc. is headquartered in West Hills, New York, United States.
What does KannaLife Sciences do?
KannaLife Sciences, Inc. is a pharmaceutical company.
When was KannaLife Sciences founded?
The earliest incorporation on record for KannaLife Sciences, Inc. is in 2010, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences